If it's sound too good to be true, it is.
I'm not so sure about that.
"The drug, which was developed by Nutra Pharma's wholly-owned drug discovery subsidiary, ReceptoPharm, will be available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating repetitive stress, arthritis, and joint pain."
Proteins and peptides undergo decomposition going through the gastrointestinal tract. Spraying it in the mouth or applying to the skin avoids much of that.
The price could be that low because these peptides from cobra venom are natural, so it can't be patented. That doesn't mean that they can't find some alternate that can't be patented.
Do you have a financial interest in Nutra Pharma?
Woo hoo ping!